D. E. Shaw & Co., Inc. Vir Biotechnology, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 930,655 shares of VIR stock, worth $6.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

930,655

Holding current value

$6.89 Million

% of portfolio

0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $58,813 - $86,680	8,101 Added 0.88%	930,655 $6.97 Million
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $2.11 Million - $3.5 Million	276,300 Added 42.75%	922,554 $8.21 Million
Q1 2024 May 15, 2024	SELL	$8.6 - $11.9 $1.06 Million - $1.46 Million	-122,890 Reduced 15.98%	646,254 $6.55 Million
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $862,035 - $1.14 Million	-111,087 Reduced 12.62%	769,144 $7.74 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $7.56 Million - $20.4 Million	826,696 Added 1544.22%	880,231 $8.25 Million
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $319,348 - $375,646	-13,765 Reduced 20.45%	53,535 $1.31 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $496,509 - $688,109	22,305 Added 49.57%	67,300 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $602,332 - $851,594	30,177 Added 203.65%	44,995 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $113,759 - $193,753	6,230 Added 72.54%	14,818 $286,000
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $832,689 - $1.17 Million	-43,642 Reduced 83.56%	8,588 $219,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $1.96 Million - $3.7 Million	-92,572 Reduced 63.93%	52,230 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $691,374 - $1.21 Million	-22,324 Reduced 13.36%	144,802 $6.06 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $1.82 Million - $2.84 Million	-52,102 Reduced 23.77%	167,126 $7.27 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $3.99 Million - $5.25 Million	102,936 Added 88.52%	219,228 $10.4 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $2.49 Million - $7.87 Million	94,721 Added 439.11%	116,292 $5.96 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $550,276 - $935,749	21,571 New	21,571 $578,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account